Spain – Various medicinal products – Suministro del medicamento cuyo Principio Activo es DARATUMUMAB para el Complejo As
Gerencia de Atención Especializada de Salamanca awarded €1.6M to JANSSEN-CILAG, S.A. for Construction & Public Works in June 2025 — one of 65 awards this buyer has made, above its typical award size.
Buying agency
Gerencia de Atención Especializada de SalamancaWinning supplier
JANSSEN-CILAG, S.A.Contract description
Spain – Various medicinal products – Suministro del medicamento cuyo Principio Activo es DARATUMUMAB para el Complejo Asistencial Universitario de Salamanca.
Related awards · Gerencia de Atención Especializada de Salamanca
65 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-768315-2024WERFEN ESPAÑA, S.A.U.€2.2M16 Dec 2024 Construction
- ocds-ted-802067-2025HORI-HORI, S.A.€1.8M03 Dec 2025 Professional Services
- ocds-ted-153119-2026JANSSEN-CILAG, S.A.€1.8M05 Mar 2026 Construction
Other wins · JANSSEN-CILAG, S.A.
122 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-292452-2026Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza€99.5M29 Apr 2026 Construction
- ocds-ted-293557-2026Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza€99.5M29 Apr 2026 Construction
- ocds-ted-660396-2025SERVICIO ANDALUZ DE SALUD. ÁREA HOSPITALARIA VIRGEN DEL ROCÍO€88.1M08 Oct 2025 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Gerencia de Atención Especializada de Salamanca and JANSSEN-CILAG, S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back